doxycycline monohydrate 100 MG Oral Capsule [Mondoxyne]
- RxCUI
- 1666542
- RxNorm name
- doxycycline monohydrate 100 MG Oral Capsule [Mondoxyne]
- Display name
- MONDOXYNE (Oral Pill)
- Full name
- doxycycline monohydrate 100 MG Oral Capsule [Mondoxyne]
- Term type
- SBD
- Status
- Active
- Strength
- 100 mg
- Dose form
- Cap
- Route
- Oral Pill
- Updated
- 2026-10-20 20:51:30
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 102015
- Active start
- 102015
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| doxycycline monohydrate | 100 MG / 1 EACH | doxycycline | doxycycline |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Capsule | 316965 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| doxycycline | 3640 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Mondoxyne 100 MG Oral Capsule | 1 | NAMES |
| RxNorm Name | doxycycline monohydrate 100 MG Oral Capsule [Mondoxyne] | 1 | NAMES |
| RxNorm Synonym | Mondoxyne 100 MG Oral Capsule | 1 | NAMES |
| TTY | SBD | 1 | ATTRIBUTES |
| RxCUI | 1666542 | 1 | CODES |
| MMSL_CODE | BD1166 | 1 | CODES |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 1f80aef4-3ca9-42ec-e054-00144ff8d46c | Mondoxyne NL 100 MG Oral Capsule [PSN] · doxycycline monohydrate 100 MG Oral Capsule [Mondoxyne] [SBD] · Mondoxyne 100 MG Oral Capsule [SY] | 3 | 1 | Monodoxyne NL 100mg | 20150911 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 816b110f-36e5-4b1e-9db4-f82c87191bc6 | Mondoxyne NL, Doxycycline Capsules, USP Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of doxycycline capsules and other antibacterial drugs, doxycycline capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | Sonoma Pharmaceuticals, Inc. | PD-Rx Pharmaceuticals, Inc. | 20191023 |
| 1f80aef4-3ca9-42ec-e054-00144ff8d46c | Monodoxyne NL 100mg | Oculus Innovative Sciences | 20150911 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | A01AB | Antiinfectives and antiseptics for local oral treatment | ATC1-4 | doxycycline | |
| ATC | J01AA | Tetracyclines | ATC1-4 | doxycycline | |
| FDASPL | D013754 | Tetracyclines | CHEM | has_chemical_structure | doxycycline |
| FDASPL | N0000175882 | Tetracycline-class Drug | EPC | has_epc | doxycycline |
| MEDRT | D004318 | Doxycycline | CHEM | has_ingredient | doxycycline monohydrate |
| MEDRT | D004318 | Doxycycline | CHEM | has_ingredient | doxycycline |
| MEDRT | D013752 | Tetracycline | CHEM | ci_chemclass | doxycycline |
| MEDRT | D013752 | Tetracycline | CHEM | ci_chemclass | doxycycline monohydrate |
| MEDRT | D000881 | Anthrax | DISEASE | may_treat | doxycycline monohydrate |
| MEDRT | D000881 | Anthrax | DISEASE | may_treat | doxycycline |
| MEDRT | D002169 | Campylobacter Infections | DISEASE | may_treat | doxycycline |
| MEDRT | D002169 | Campylobacter Infections | DISEASE | may_treat | doxycycline monohydrate |
| MEDRT | D002675 | Child, Preschool | DISEASE | ci_with | doxycycline monohydrate |
| MEDRT | D002675 | Child, Preschool | DISEASE | ci_with | doxycycline |
| MEDRT | D002771 | Cholera | DISEASE | may_treat | doxycycline monohydrate |
| MEDRT | D002771 | Cholera | DISEASE | may_treat | doxycycline |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | doxycycline monohydrate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | doxycycline |
| MEDRT | D006100 | Granuloma Inguinale | DISEASE | may_treat | doxycycline |
| MEDRT | D006100 | Granuloma Inguinale | DISEASE | may_treat | doxycycline monohydrate |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | doxycycline monohydrate |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | doxycycline |
| MEDRT | D008288 | Malaria | DISEASE | may_prevent | doxycycline |
| MEDRT | D008288 | Malaria | DISEASE | may_prevent | doxycycline monohydrate |
| MEDRT | D009175 | Mycoplasma Infections | DISEASE | may_treat | doxycycline |
| MEDRT | D009175 | Mycoplasma Infections | DISEASE | may_treat | doxycycline monohydrate |
| MEDRT | D010930 | Plague | DISEASE | may_treat | doxycycline |
| MEDRT | D010930 | Plague | DISEASE | may_treat | doxycycline monohydrate |
| MEDRT | D010996 | Pleural Effusion | DISEASE | may_treat | doxycycline monohydrate |
| MEDRT | D010996 | Pleural Effusion | DISEASE | may_treat | doxycycline |
| MEDRT | D018410 | Pneumonia, Bacterial | DISEASE | may_treat | doxycycline monohydrate |
| MEDRT | D018410 | Pneumonia, Bacterial | DISEASE | may_treat | doxycycline |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | doxycycline monohydrate |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | doxycycline |
| MEDRT | D009956 | Psittacosis | DISEASE | may_treat | doxycycline monohydrate |
| MEDRT | D009956 | Psittacosis | DISEASE | may_treat | doxycycline |
| MEDRT | D012061 | Relapsing Fever | DISEASE | may_treat | doxycycline monohydrate |
| MEDRT | D012061 | Relapsing Fever | DISEASE | may_treat | doxycycline |
| MEDRT | D012373 | Rocky Mountain Spotted Fever | DISEASE | may_treat | doxycycline monohydrate |
| MEDRT | D012373 | Rocky Mountain Spotted Fever | DISEASE | may_treat | doxycycline |
| MEDRT | D012598 | Sclerosis | DISEASE | induces | doxycycline |
| MEDRT | D012598 | Sclerosis | DISEASE | induces | doxycycline monohydrate |
| MEDRT | D013587 | Syphilis | DISEASE | may_treat | doxycycline monohydrate |
| MEDRT | D013587 | Syphilis | DISEASE | may_treat | doxycycline |
| MEDRT | D014141 | Trachoma | DISEASE | may_treat | doxycycline |
| MEDRT | D014141 | Trachoma | DISEASE | may_treat | doxycycline monohydrate |
| MEDRT | N0000000150 | Protein Synthesis Inhibitors | MOA | has_moa | doxycycline monohydrate |
| MEDRT | N0000000150 | Protein Synthesis Inhibitors | MOA | has_moa | doxycycline |
| MEDRT | N0000008334 | Cell Membrane Alteration | PE | has_pe | doxycycline monohydrate |
| MEDRT | N0000008334 | Cell Membrane Alteration | PE | has_pe | doxycycline |
| MEDRT | N0000008732 | Decreased Mitosis | PE | has_pe | doxycycline monohydrate |
| MEDRT | N0000008732 | Decreased Mitosis | PE | has_pe | doxycycline |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | doxycycline monohydrate |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | doxycycline |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 100 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| NAMES | Prescribable Synonym | Mondoxyne NL 100 MG Oral Capsule |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Multum MediSource Lexicon |